Skip to main content
Clinical Trials/NL-OMON40203
NL-OMON40203
Completed
Not Applicable

Validity of the Steep Ramp Test to assess exercise capacity in patients with cancer undergoing chemotherapy - START

ederlands Kanker Instituut0 sites50 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
cancer and exercise tolerance during chemotherapy treatment
Sponsor
ederlands Kanker Instituut
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
ederlands Kanker Instituut

Eligibility Criteria

Inclusion Criteria

  • Patients with cancer who will undergo chemotherapy and who have decided to participate in a physiotherapeutic intervention during their chemotherapy treatment.
  • Approval of treating physician to participate in this study.

Exclusion Criteria

  • Patients with comorbid conditions which would contraindicate participation to a VO2max test.
  • 1\. Serious orthopedic conditions
  • 2\. Serious cardiovascular or cardiopulmonary conditions (or risks)
  • Patients with a high risk profile for cardiovascular events according to the ACSM guidelines
  • 3\. Patients suffering from malnutrition as evidenced by a BMI \< 18 kg/m2, unintended weight loss of more than 5% per month, or more than 10% unintended weight loss during the previous 6 month
  • 4\. Serious psychiatric or cognitive problems
  • 5\. Lack of basic fluency in the Dutch language.

Outcomes

Primary Outcomes

Not specified

Similar Trials